Caveolin-1 (Cav-1) is essential for the morphology of membrane caveolae and exerts a negative influence on a number of signaling systems, including NO production and activity of the MAP kinase cascade. In the vascular system, ablation of caveolin-1 may thus be expected to cause arterial dilatation and increased vessel wall mass (remodeling). This was tested in Cav-1 knockout (KO) mice by a detailed morphometric and functional analysis of mesenteric resistance arteries, shown to lack caveolae. Quantitative morphometry revealed increased media thickness and media-to-lumen ratio in KO. Pressure-induced myogenic tone and flowinduced dilatation were decreased in KO arteries, but both were increased towards wild-type (WT) levels following nitric oxide synthase (NOS) inhibition. Isometric force recordings following NOS inhibition showed rightward shifts of passive and active length-force relationships in KO, and the force response to 1 -adrenergic stimulation was increased. In contrast, media thickness and force response of the aorta were unaltered in KO vs. WT, whereas lumen diameter was increased. Mean arterial blood pressure during isoflurane anesthesia was not different in KO vs. WT, but greater fluctuation in blood pressure over time was noted. Following NOS inhibition fluctuations disappeared and pressure increased twice as much in KO (38±6%) compared to WT (17±3%). Tracer dilution experiments showed increased plasma volume in KO. We conclude that NO affects blood pressure more in Cav-1 KO than in WT mice and that restructuring of resistance vessels and an increased responsiveness to adrenergic stimulation compensate for a decreased tone in Cav-1 KO mice.
presence of L-NAME (300µM), and in the presence of indomethacin (10 µM). Inhibitors were prepared on the day of the experiment.
Morphometry and immunofluorescence
Following relaxation in Ca 2+ -free solution for 30 min, aortic segments and SMAs, adjacent to those used in the mechanical experiments, were fixed with 2 % formaldehyde in phosphate buffered saline (PBS, pH 7.4) for 30 min. In a subset of experiments 20 ml fixative was infused through the femoral artery (see in vivo experiments below) while blood was allowed to leave through the jugular vein. This was done following full arterial dilatation with sodium nitroprusside (Sigma, St. Louis, MO), which was given as bolus doses (10 nmol in 10 µl) until the blood pressure reduction saturated. Blood pressure was 40±2 mmHg in WT and 34±3 mmHg in KO following nitroprusside saturation (p=0.08, n=7 for both). Arteries were then removed and maintained in fixative for another 30 min. Fixed specimens were washed in PBS containing 10 % sucrose and methylene blue (2x10 min) followed by embedding in TissueTek (Sakura, Zoeterwoude, Netherlands). After freezing, 10 µm cross sections were obtained in a cryostat. For morphometry, sections were stained with hematoxylin-eosin (Merck, Darmstadt, Germany) or Masson's Trichrome (Biocare Medical LLC, Concord, CA, USA)
following the manufacturers instructions, and media thickness, area, and internal circumference were determined using a computerized image analysis system (Leica Q500MC). At least four glasses from each mouse were used. Media thickness was obtained from four averaged measurements in positions defined by two perpendicular diameters. Transmission Electron Microscopy 1 st generation small mesenteric arteries were dissected in Ca 2+ -free HEPES buffered Krebs solution, cut into small pieces (~30, <0.3 mm length), and opened in the longitudinal direction to minimize diffusion distances for the fixative. Following transfer to 1.5 ml Eppendorf tubes, preparations were allowed to settle at the bottom, and the physiological buffer was aspirated and exchanged for fixative containing 2.5% glutaraldehyde in 0.15M sodium cacodylate, pH 7.4. This was repeated once to remove all physiological buffer, and fixation was allowed to proceed over night. Samples were washed with sodium cacodylate, postfixed for 1 hour in 1% osmium tetroxide in sodium cacodylate, and finally washed with sodium cacodylate. They were dehydrated with an ascending ethanol series and embedded in Agar 100Resin R1031 medium using acetone as an intermediate solvent. Specimens were sectioned into 50 nm ultrathin sections and stained with uranyl acetate and lead citrate. Specimens were observed in a Philips CM10 electron microscope operated at 60 kV. Images were recorded on Kodak SO-163 plates without preirradiation at a dose of 2.000 electrons/nm 2 .
Western blotting
Western blotting using the Cav-3 antibody (see above) was performed as described (27), with dilutions recommended by the manufacturer. SMAs from one mouse gave insufficient protein for reliable quantification. Therefore, SMAs from three mice were combined for each homogenate (n=1), whereas single aortas and portal veins were used for individual homogenates. Protein concentration was determined with a Bio-Rad protein assay (Bio-Rad, Hercules, CA, USA), and equal amounts of protein were loaded in all lanes. To illustrate equal loading, non-transferred proteins were stained with Comassie blue and a section around the actin band is shown.
Organ culture
To assess DNA synthesis independent of hemodynamic conditions in vivo, whole mesenteric arterial trees were subjected to organ culture. SMA trees were dissected under sterile conditions, and blood was removed from the lumen by gentle stroking with a rubber policeman. Following weighing, preparations were cultured in DMEM-HAM's F12 medium
(1:1) with 2% dialyzed fetal calf serum and 10 nM insulin, and with the addition of 50 U/ml penicillin and 50 µg/ml streptomycin, for 4 days. 3 H-thymidine (10 µCi, Amersham Biosciences Europe, Uppsala, Sweden) was added during the last 24h of culture. On harvesting, preparations were washed in ice-cold PBS and frozen in liquid nitrogen.
Following freeze crushing, preparations were dissolved in 400 µl 0.2 M NaOH, sonicated twice, and 300 µl was removed. Following two cycles of precipitation with trichloroacetic acid (5% TCA), centrifugation (13200 g), and washing (5% TCA), the supernatant was discarded and the pellet resuspended in Soluene. After 2h, 8 ml of liquid scintillation cocktail was added, and preparations were subjected to scintillation counting (Beckman LS6500, Beckman Instruments Inc., Fullerton, CA, USA). Protein concentration was determined in the remaining homogenate (100 µl) using the Bio-Rad protein assay. Radioactive counts were divided by the amount of protein and normalized to WT (100%) in each experiment.
In vivo experiments
Mice were placed in a small container and surgical anesthesia was induced with 4% isoflurane Mean arterial blood pressure, obtained by low-pass filtering the pressure data using the Grass Instrument, was recorded for at least 45 min prior to the infusion of L-NAME. L-NAME was given as a bolus (5 µmol in 50 µl) followed by continuous infusion (23 mM at a rate of 7 µl/min) to uphold a constant plasma concentration. L-NAME was infused for 1h, but pressure stabilized at a higher level within a few minutes. Heart rate was obtained by removing the low-pass filter and increasing chart speed at regular intervals during the experiment.
Experiments were carried out in a blinded manner and genotypes were only revealed following complete analysis.
For plasma volume determination, mice were allowed to stabilize for 20 min following surgery. Tracer amounts of 125 I-HSA (Human Serum Albumin-I-125, RISA, 3mg/ml, 5MBq, Amersham Health) were administered in the right jugular vein. To reduce the amount of free iodine the 125 I-HSA was filtered prior to administration using Amicon YM-30 (Millipore, Bedford, MA). Immediately after the injection, the catheter was removed and the vein ligated.
To determine the amount of 125 I-HSA injected, the vial containing the tracer was counted for radioactivity prior to injection, and then compared with the amount left in the vial and in the equipment involved. The injected volume was kept at 50±20µl. Four 10-µl-blood samples were collected at 5, 20, 40 and 60 minutes after injection. The catheter was filled with heparinised saline, which was temporarily removed during sampling. After the last blood sample 80-µl blood was drawn for hematocrit measurement. Radioactivity measurements were performed in a gamma counter (Wizard 1480, LKP Wallac, Turku, Finland). The amount of radioactivity in plasma (cpm/ml) was plotted vs. time in a semi logarithmic diagram. The data was fitted using an exponential regression function (y = a*e -bx
) and the tracer concentration was extrapolated to time zero. Plasma volume was finally calculated by dividing the total amount of radioactivity injected into the mouse by the plasma tracer concentration at t=0.
Chemicals and reagents
Unless specified chemicals and reagents were obtained from Sigma (Sigma, St. Louis, MO).
Statistics
Mean values ± SEM are shown. Student's t-test for unpaired data, or, in case of multiple comparisons, ANOVA followed by Bonferroni's post hoc test, was used to calculate statistical significance.
with almost complete loss of caveolae in aortic and bladder smooth muscle (5, 31), caveolae appeared to be absent in the media of KO SMA as illustrated in Fig 2F .
Increased 1 -adrenergic contraction in KO SMA but not in aorta
An increased media thickness in KO would be associated with increased arterial force development, which may however be masked by increased NO production. To eliminate NO production, arteries were denuded and the NOS inhibitor L-NAME (300 µM) was included.
Cumulative concentration-response curves using the selective 1 -receptor agonist cirazoline revealed greater force in KO compared to WT at all concentrations exceeding 0.1 µM ( WT was maximal after 7-10 min stimulation, and was less pronounced during early and late phases of contraction. Peak force was significantly greater in KO (Fig. 3D ). The K + -channel inhibitor tetraethylammonium was then added to optimize conditions for force generation.
Noradrenaline-induced force was greater also following K + -channel inhibition (TEA, 20 mM, Fig. 3D ).
Arterial remodeling in Cav-1 -/-mice
To assess arterial structure quantitatively, vascular sections were fixed and stained with H&E or Masson's trichrome for morphometry (Fig. 4A ). The analysis indicated increased media thickness and media area in small mesenteric arteries (Fig. 4B ). Trichrome staining did not indicate increased connective tissue deposits in KO compared to WT, and did not reveal any obvious change in adventitial thickness (Fig. 4A ). In the aorta, the internal circumference was increased, whereas the media thickness was unchanged (Fig. 4B) . In SMA the internal circumference was not significantly different between KO and WT either in immersion-fixed (WT: n=12, KO: n=8) or perfusion-fixed (WT: n=3, KO: n=5) preparations, and there was no significant difference in circumference between these two fixation methods in either genotype. However, lumen dimensions are highly dependent on pressure and might be affected by fixation conditions. In Fig 4 the pooled data are shown, but lumen dimensions were also determined in live arteries at defined pressure levels as described below.
SMAs were mounted in a pressure myograph and vessel dimensions determined using a CCD camera and an edge detection system (see METHODS). Measurements were made in the absence of extracellular Ca 2+ to abolish arterial tone. Passive pressure-diameter relationships were determined as shown in Figure 6A below. At an intraluminal pressure of 95 mmHg lumen diameter was not significantly different in KO (257±9 µm) vs. WT (242±12 µm, n=11, p>0.05). From the edge detection system wall thickness was estimated as 24±2 µm in KO vs.
14±1 µm in WT (n=12, p<0.001) and wall cross sectional area to 2.2 ±0.2 x 10 4 µm 2 vs.
1.2±0.1 x 10
4 µm 2 (n=12, p<0.001). Importantly, the wall-to-lumen ratio was greater in KO (0.096±0.006 vs. 0.063±0.006, n=12, p<0.001). These measurements refer to the total wall thickness as determined by the CCD camera, so to get an estimate of the media-to-lumen ratio, the media areas determined histologically (Fig. 4A ) were used to calculate the expected media thickness at the pressure levels and diameters shown in Fig 6A. At all pressure levels above 20mmHg, the media-to-lumen ratio was higher in KO; e.g. at 95 mmHg it was 0.048 vs. 0.036.
To address if the changes in arterial structure would translate into an altered optimal circumference for generation of active force (L 0 ), circumference-tension relationships in endothelium-denuded SMA were generated under isometric conditions using the wire myograph. The relationship between internal circumference and active force on depolarization with high-K + solution (60 mM) was shifted to the right in KO compared to WT (Fig. 5A) , as was the relationship between circumference and passive force (Fig. 5B) . Determination of the optimum for force development in each experiment revealed a significant increase of L 0 in KO (Fig. 5C ). Small arteries in Cav-1 deficient mice thus have a hypertrophic muscle layer and exhibit signs of outward remodeling, but have increased wall to lumen ratio.
Increased rate of thymidine incorporation in SMA
To assess DNA synthesis independent of hemodynamic conditions in vivo, whole mesenteric arterial trees were subjected to organ culture, and thymidine incorporation was measured.
Consistent with a thicker media, mesenteric artery trees weighed more in KO than in WT 
Myogenic tone
To test properties of tone in KO compared to WT arteries in an integrated setting, experiments were run in the pressure myograph. In a first series of experiments pressure was increased in steps from 20 to 120 mmHg to produce myogenic tone. Passive lumen diameter was significantly increased in KO compared to WT over the pressure range 20 to 50 mmHg (Fig.   6A ). Active lumen diameter was significantly increased in the KO over the entire pressure range (Fig. 6B) . Consistent with earlier findings (1, 7), myogenic tone (% reduction in diameter on activation, see Methods) was considerably lower in KO compared to WT SMAs (Fig. 6C ). L-NAME increased myogenic tone in KO, but it was still significantly lower than in WT. No effect of L-NAME on myogenic tone was observed in WT.
Flow-induced dilatation and combined tone
We next examined flow-induced dilatation at 95 mmHg and with the combination of 1 -agonist and pressure. Flow caused a rate-dependent reduction of myogenic tone in WT SMAs (Fig. 6D) . In KO SMAs that had developed myogenic tone, flow-induced dilatation was absent (Fig. 6D) . Treatment with L-NAME conferred on the KO arteries an ability to dilate in response to increased flow, but did not affect flow-induced dilatation in WT (Fig. 6E) .
Moreover, flow-induced dilatation was not different in KO compared to WT following precontraction with the 1 -adrenergic agonist cirazoline (combined tone, Fig. 6F ). Neither L-NAME nor indomethacin inhibited flow-mediated dilatation under combined tone, suggesting that dilatation was due to a mechanism independent of NOS and cyclooxygenase.
To illustrate differences between tone induced by pressure alone and by the combination of pressure and adrenergic stimulation (combined tone), data at 95 mmHg in Figure 6C and F were replotted in Figure 7 . The difference in myogenic tone between KO and WT was greater than was the difference in combined tone (compare 7A and B). This was seen both in the absence and presence of flow (not shown). Addition of L-NAME did not eliminate the difference in myogenic tone between WT and KO (Fig. 7A) , but eliminated the difference between WT and KO during combined tone (Fig. 7B) . The lower myogenic tone was therefore compensated by a relatively greater diameter change in response to adrenergic stimulation, so that the combined tone differed less, or not at all.
Plasma volume expansion
Anesthetized WT (n=7) and KO (n=8) mice were injected with tracer amounts of 125I-HSA.
The concentration of tracer in plasma decreased in an exponential manner for both WT and KO, with the correlation coefficients for the average curves being 0.96 and 0.95, respectively.
The plasma volume was significantly increased in KO (6.0±0.3 ml/100g bodyweight) 
Blood pressure following NOS inhibition
Blood pressure and heart rate were recorded in WT and KO mice (Fig. 8A) in the presence and absence of L-NAME. Consistent with previous data (26) blood pressure was similar in WT and KO mice prior to L-NAME administration (Fig. 8B) , while heart rate was slightly but significantly increased in KO in the present series (Fig. 8C) . The relative increase in blood pressure on administration of L-NAME was 17±3% in WT and 38±6% in KO (n=11 and 6, p=0.001), illustrating the greater influence of NO on blood pressure in KO. Following L-NAME, blood pressure was significantly greater in KO compared to WT, with no difference in heart rate ( Fig. 8B and C) . We also observed greater blood pressure variability in KO mice as evident from the blood pressure records in Fig. 8A . These slow fluctuations disappeared following L-NAME administration.
Discussion
The high basal NO production (5, 23, 32, 35), the major reduction of myogenic tone (1, 5, 7), and the age-dependent development of cardiac dysfunction (4, 32, 35) in Cav-1 deficient mice would be expected to result in lowered systemic blood pressure. This has not been seen to occur in adult Cav-1 deficient (KO) mice (26) . The hypotheses that loss of Cav-1 is associated with arterial remodeling, increased 1 -adrenergic contraction, and plasma volume expansion were therefore tested. Consistent with the hypotheses, small mesenteric arteries were remodeled in Cav-1 deficient mice, and 1 -adrenergic contraction was increased under isometric conditions. Moreover, a modest (14%) increase in plasma volume was detected.
Mean arterial blood pressure was normal in KO mice compared to WT, as was also shown in a previous study (26) . Following nitric oxide synthase inhibition, blood pressure was higher in KO than in WT, indicating the presence of blood pressure elevating changes masked by increased NO-mediated dilatation.
Remodeling was present in the splanchnic circulation (present study), and possibly in the hind limb (20, 27) . In contrast, the aorta exhibited an increase in circumference but not in media thick ness or force development. Although the precise mechanisms of remodeling are debatable, some predictions can be made from the architectural reorganization. As pointed out by Folkow (8), an increased wall-to-lumen ratio is of advantage for controlling vascular diameter and resistance. Indeed, a 30 % shortening of the outer muscle layer would increase resistance 7-fold using the geometry in WT mesenteric arteries (media thickness: 11 µm, radius: 103 µm), whereas resistance would increase 11-fold in KO arteries (media thickness:
17 µm, radius: 103 µm), as calculated using Poiseuille's law. Thus, a more efficient control of vascular resistance conferred on small arteries by increased wall-to-lumen ratio may contribute to a greater blood pressure response to vasoconstrictor stimuli in KO than in WT.
We noted increased wet weight and protein contents in KO compared to WT small mesenteric arteries, and slightly higher rates of thymidine incorporation in organ culture. This is consistent with the negative regulatory role of Cav-1 in cellular growth and proliferation (10-13, 17, 23, 30) . This effect may contribute to medial hypertrophy. However, other possible mechanisms may play a role. Arterial dilatation at unaltered blood pressure will lead to increased arterial wall tension, which is a powerful stimulus for growth signaling in smooth muscle (14) . Aorta, in contrast to small mesenteric arteries, did not show significant media hypertrophy despite increased diameter in the KO. This may be related to the fact that the aorta is a conduit vessel essentially without resistance function, and that elastic fibers rather than smooth muscle cells carry the major part of its wall tension.
Responsiveness to 1 -adrenergic agonists in denuded small mesenteric arteries in the presence of L-NAME was increased in Cav-1 KO arteries. It was previously shown that 1 Cav-3 expression was reduced in the absence of Cav-1 in several vascular preparations. This is consistent with data in the femoral artery (27), but differs from results in striated muscle (5). Because caveolae were absent, as seen by electron microscopy, it must be assumed that the contribution of Cav-3 to caveolae formation in the SMA media is minimal. Our ability to detect Cav-3 in venous smooth muscle, in which it is often undetectable, may relate to the use of very sensitive blotting reagents. The possible role played by Cav-3 in smooth muscle may be addressed using Cav-3 deficient mice.
Myogenic tone stimulated by increased intraluminal pressure (the Bayliss effect) was reduced in small mesenteric arteries from Cav-1 deficient mice, which is in keeping with previous studies (1, 5, 7). Our data reveal that myogenic tone partly recovered after L-NAME. This indicates that increased basal NO release plays a considerable role in the impairment of this hemodynamic autoregulatory mechanism in small mesenteric arteries. The impairment of myogenic tone remaining after L-NAME may involve reduced RhoA/Rho-kinase activation as suggested by Dubroca et al (7), and functional activation of K Ca channels as proposed by
Adebiyi et al (1) . Addition of L-NAME in the presence of 1 -agonist at 95 mmHg (combined tone) increased KO tone to the same level as that in identically treated WT arteries. This indicates a greater contribution to tone of 1 -adrenergic as compared to myogenic mechanisms in KO vs. WT arteries in an integrated setting, such that the entire difference in tone between KO and WT is eliminated in the presence of L-NAME.
The endothelium responds acutely to shear stress by increasing eNOS activity and NO production through a process involving caveolae (25) . Accordingly, flow-mediated dilatation in adrenergically stimulated carotid arteries, which in part depends on NO, was recently shown to be impaired in Cav-1 deficient mice (33) . In SMA, we found that flow-induced dilatation of myogenic tone is reduced in Cav-1 deficient mice. However, flow-induced dilatation recovered when eNOS was inhibited and tone increased. Furthermore, no difference in flow-mediated dilatation was found when vessels were constricted by activation of 1 -adrenergic receptors and pressure. Thus the level of tone is an important determinant of the ability to dilate in response to flow, and this dilatation in the SMA seems to be largely independent of NO production, in accordance with earlier findings of NO-independent endothelium-mediated dilatation of resistance vessels in mice (3).
Plasma volumes and hematocrit values determined in the present study to calculate blood volume in a 25 g mouse yields 2.5 ml in KO vs. 2.2 ml in WT. This represents a 14% greater blood volume in the caveolin-1 deficient mice. Plasma volume expansion may be secondary to heart failure (16), and is expected to increase ventricular diastolic filling pressure, which indeed has been reported to be increased in KO (32) . Importantly, increased ventricular filling would compensate reduced cardiac contractility, and thus improve cardiac output. Activation of the renin-angiotensin system and increased levels of vasopressin may mediate changes in plasma volume and contribute to blood pressure normalization, but to our knowledge concentrations of these mediators in plasma have not been determined in the Cav-1 deficient mouse model.
Blood pressure was stated to be reduced in KO mice in one previous study (32) , but no data were presented. Moreover, blood pressure was reported to be increased in the lung (35) in KO mice. The present study, and our previous work (26) , reveals no effect of Cav-1 ablation on mean systemic blood pressure. The effect of L-NAME, however, was doubled in KO vs. WT indicating a much greater influence of NO on blood pressure. This likely reflects alleviated Cav-1 inhibition of NOS activity (4, 5, 18, 23, 35). Heart rate was slightly increased in the absence of L-NAME, but not in its presence, suggesting baroreceptor reflex activation in the former situation.
In conclusion, the present study has shown that arterial remodeling and increased 1 -adrenergic contraction in Cav-1 deficient mice compensate for a reduced myogenic tone in maintaining blood pressure. Moreover, enhanced NO release caused by loss of Cav-1 impairs myogenic reactivity, and plays a greater role for blood pressure as revealed by L-NAME. 
